about
New insights into the pathophysiology of achalasia and implications for future treatmentThe Mexican consensus on irritable bowel syndrome.Randomised clinical trial: mixed soluble/insoluble fibre vs. psyllium for chronic constipation.Translumbar and transsacral magnetic neurostimulation for the assessment of neuropathy in fecal incontinence.Brain and gut interactions in irritable bowel syndrome: new paradigms and new understandings.Accuracy and Reproducibility of High-definition Anorectal Manometry and Pressure Topography Analyses in Healthy Subjects.Achalasia--An Autoimmune Inflammatory Disease: A Cross-Sectional Study.Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and/or fungal overgrowthClinical utility of colonic manometry in slow transit constipation.Treatment of esophageal (noncardiac) chest pain: an expert review.Esophageal hypomotility and spastic motor disorders: current diagnosis and treatment.Mexican consensus on dyspepsia.Post-fundoplication symptoms and complications: Diagnostic approach and treatment.The Mexican consensus on probiotics in gastroenterology.Quality of life in patients with different constipation subtypes based on the Rome III criteria.Evaluation of constipation in older adults: radioopaque markers (ROMs) versus wireless motility capsule (WMC).Editorial: mixed soluble fibre in chronic constipation - something new? Authors' reply.Cytomegalovirus Infection in Patients Who Required Colectomy for Toxic Megacolon or Severe Steroid-Refractory Ulcerative ColitisThe effect of voluntary pharyngeal swallowing maneuvers on esophageal swallowing physiologySymptomatic recurrence upon proton pump inhibitor discontinuation correlated with results of Bravo® wireless esophageal pH monitoring in patients with gastroesophageal reflux diseaseHistopathologic patterns among achalasia subtypes
P50
Q28068914-8789F286-CB32-4C4B-AD4B-AFD0A1A19C1FQ30251782-306A8ACC-902A-4823-9743-D947F035B235Q33467821-0055FD81-AE2C-4BA1-8F03-2E2E52E3E3C4Q33606308-553B91A4-E2C7-4DFA-B3CF-4649FC264151Q33851444-0D6FFC78-F834-4E84-A551-0430BC837789Q35639640-D22EACE4-9193-4698-8882-BFF668F27634Q35675896-D9DA14D1-7E22-4DA0-AF6D-8F151DA820AEQ37150742-1FBB8F15-BE89-4FFF-9E69-E688BB3DF595Q37150811-4B359C55-CCE5-4200-BD45-E972E3439413Q38133196-704F3E3E-42D2-4522-8ED3-95DE3664AE06Q38265795-9007765F-B5DD-4399-89E3-62B7721DD4EAQ38835167-C049D4DA-8958-4DD4-93E8-D1F1E32E02C9Q39074790-0243D4FD-ADEB-4B5D-B233-820B57B5C0C6Q39095486-7AFC057F-4DBB-4C57-B224-7FB45A2778D7Q41334039-563E497C-17F5-45B0-8042-553FC9288E55Q44216462-7199B702-B406-4B7F-8E74-52D4D8F1238AQ48176804-17C1488C-3288-40A0-B133-24954F5F35B9Q57735564-194FFFDC-CD46-4C6A-A079-171CAEF80673Q87036442-38901CF1-4172-4782-9B46-60BA607796E0Q88828062-795D70C1-1A0C-4831-9225-4C268C183549Q89053642-0EF2F991-66AF-4EFE-92F1-7C7752400502
P50
description
researcher ORCID ID = 0000-0002-8569-2792
@en
wetenschapper
@nl
name
E Coss-Adame
@ast
E Coss-Adame
@en
E Coss-Adame
@es
E Coss-Adame
@nl
type
label
E Coss-Adame
@ast
E Coss-Adame
@en
E Coss-Adame
@es
E Coss-Adame
@nl
prefLabel
E Coss-Adame
@ast
E Coss-Adame
@en
E Coss-Adame
@es
E Coss-Adame
@nl
P1153
35316804700
P214
8422155769103027880003
P31
P496
0000-0002-8569-2792
P7859
lccn-n2019184606